CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Tomotherapy Treatment Planningdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00124488
NCT00124488N/ACompleted

Comparison of Tomotherapy Versus Intensity-modulated Step-and-shoot and Conventional Radiation Treatment Plans for Patients With Locally-advanced Squamous Cell Carcinoma of the Cervix

Alberta Health services·observational·Posted Jul 28, 2005·Updated Dec 9, 2011

In Brief

An observational study evaluating Tomotherapy Treatment Planning for Cervix Neoplasm. Completed, across 1 site.

Detailed Summary

Standard treatment for non-operable cervix cancer is radiation and chemotherapy. This treatment combination can result in significant radiation side-effects involving the bladder, small bowel and rectum. To improve results with radiation/chemotherapy, higher radiation doses have been tried for cervix cancer patients. Results from using higher radiation doses show that cervix tumours may be better controlled, but the radiation side-effects are worsened. Intensity modulated radiotherapy (IMRT) and Tomotherapy are new radiation planning and delivery technologies which may allow for delivery of higher radiation doses with less damage to normal organs. The purpose of this project is to determine whether or not IMRT and/or Tomotherapy technology can produce radiation plans that deliver higher doses of radiation to the tumor and lower doses to normal organs when compared to standard radiation plans. The results from this project will provide the basis for possibly treating future cervix cancer patients with Tomotherapy and providing them with improved cure rates along with decreased rates of radiation side effects. No patients will be treated on this protocol, as the investigators plan to only compare radiation dose calculations from different treatment plans created for test cervix cancer cases. There will be absolutely no patient contact in this protocol.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCervix Neoplasm
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 28, 2005
Enrollment StartJun 1, 2005
Study CompletionNov 1, 2005
TodayJul 2, 2026
Posted 20.9 years ago

Interventions

Tomotherapy Treatment Planningdevice